InsidersTradesSigma
Marinomed Biotech AG: management transactions · Austria · FMA (OeKB OAM)
FMA:marinomed-biotech-agATMARINOMED6AT·FMA (OeKB OAM)Mcap 27M€Healthcare & Pharma
Browse the full management transaction log of Marinomed Biotech AG, a listed issuer based in Austria. Shares are listed on AT AT, under the supervision of FMA (OeKB OAM). Operating in the Healthcare & Pharma sector, Marinomed Biotech AG has published 23 public disclosures. Market capitalisation: €26.7m. The latest transaction was disclosed on 15 April 2026 — Purchase. Among the most active insiders: Unknown. All data is openly available.
23
Insider Decl.
0
Thresholds
€201m
10 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2024 · cache
9.85 €
Income statement
Revenue4.7 M€
Gross profit980 k€21% margin
Net income−15.4 M€-324.8% margin
Balance sheet & cash
Market cap26.7 M€
Total debt28.2 M€
Free Cash Flow−2.4 M€
Last declaration on 15 April 2026
Declarations23 total
Executives●Purchase7FMA-AT
€4,998357 shares@ €14.001.1% of flow
Share
FMA:247695·
Ideal exit: 8 Jan 2027 (T+270)
Executives●Purchase15FMA-AT
€4,998357 shares@ €14.00100.0% of flow
Share
FMA:247691·
Ideal exit: 8 Jan 2027 (T+270)
Executives●Other11FMA-AT
€462,44833,032 shares@ €14.0098.9% of flow
Share
FMA:247190·
Executives●Other23FMA-AT
€462,44833,032 shares@ €14.001.73% mcap98.9% of flow
Share
FMA:247186·
Executives●Other18FMA-AT
€115,9107,885 shares@ €14.700.43% mcap100.0% of flow
Share
FMA:217081·
Executives●Purchase18FMA-AT
€21,0001,500 shares@ €14.000.079% mcap50.0% of flow
Share
FMA:216982·
Ideal exit: 5 Oct 2025 (T+270)
Executives●Purchase16FMA-AT
€25,2655,053 shares@ €5.000.095% mcap33.9% of flow
Share
FMA:204313·
Ideal exit: 15 Jun 2025 (T+270)
Executives●Purchase21FMA-AT
€211,6435,634.4 shares@ €37.56270.79% mcap0.1% of flow
ShareVienna Stock Exchange MIC
FMA:187466·
Ideal exit: 15 Jan 2024 (T+270)
Executives●Purchase23FMA-AT
€399,4246,320 shares@ €63.201.50% mcap0.2% of flow
ShareVienna Stock Exchange MIC
FMA:178676·
Ideal exit: 12 Jun 2023 (T+270)
Executives●Purchase9FMA-AT
€40m632,000 shares@ €63.2020.2% of flow
ShareVienna Stock Exchange MIC
FMA:178670·
Ideal exit: 12 Jun 2023 (T+270)
Executives●Purchase15FMA-AT
€157m1,772,340 shares@ €88.61779.5% of flow
ShareVienna Stock Exchange MIC
FMA:166067·
Ideal exit: 11 Sept 2022 (T+270)
Executives●Purchase42FMA-AT
€1m16,200 shares@ €90.005.47% mcap50.9% of flow
ShareOutside a trading venue News
FMA:165265·
Ideal exit: 29 Aug 2022 (T+270)
Executives●Purchase42FMA-AT
€1m18,750 shares@ €75.005.27% mcap49.1% of flow
ShareOutside a trading venue News
FMA:149376·
Ideal exit: 12 Sept 2021 (T+270)
Executives●Other0FMA-AT
FMA:139872·details not loaded
Executives●Other0FMA-AT
FMA:137486·details not loaded
Executives●Other0FMA-AT
FMA:125554·details not loaded
Executives●Other0FMA-AT
FMA:125550·details not loaded
Executives●Other0FMA-AT
FMA:125017·details not loaded
Executives●Other0FMA-AT
FMA:125011·details not loaded
Executives●Other0FMA-AT
FMA:125007·details not loaded
Executives●Other0FMA-AT
FMA:124918·details not loaded
23 of 23 declarations
